A pillot study to examine the safety and efficacy of intravitreal ranubizimab/dexamethasone administration and oral minocycline in addition to Visudyne (verteporfin) photdynamic therapy for subfoveal choroidal neovascularization secondary to age related macular degeneration degeneration: an open label trial.
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Dexamethasone (Primary) ; Minocycline (Primary) ; Ranibizumab (Primary) ; Verteporfin (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- 31 Jul 2017 New trial record